Recent progress in 5-HT6 receptor antagonists for the treatment of CNS diseases

Author： Slassi Abdelmalik Isaac Methvin O’Brien Anne

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.4, 2002-04, pp. : 513-527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serotonin 5-HT6 Receptor Antagonists for the Treatment of Alzheimer's Disease

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 12, 2008-08 ,pp. : 1035-1048

Bentham Science Publishers

Access to resources Recommend Favorite

New Treatment Options Using 5-HT3 Receptor Antagonists in Rheumatic Diseases

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 18, 2006-09 ,pp. : 2035-2042

Bentham Science Publishers

Access to resources Recommend Favorite

5-HT6 Receptor Antagonists: Potential Efficacy for the Treatment of Cognitive Impairment in Schizophrenia

Current Pharmaceutical Design, Vol. 21, Iss. 26, 2015-01 ,pp. : 3739-3759

Bentham Science Publishers

Access to resources Recommend Favorite

Recent progress in 5-HT₇ receptors: potential treatment of central and peripheral nervous system diseases

By Slassi Abdelmalik Isaac Methvin Xin Tao

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 7, 2004-07 ,pp. : 1009-1027

Informa Healthcare

Access to resources Recommend Favorite

5-HT6 Receptor Antagonists as Potential Therapeutics for Cognitive Impairment

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 2, 2010-02 ,pp. : 207-221

Bentham Science Publishers

Access to resources Recommend Favorite